AFINITOR

Manufacturer:

Novartis

Name:

AFINITOR

HCPCS Code Descriptor:

Everolimus, oral, 0.25 mg

Category:

J Code

HCPCS:

J7527

NDC(s):

00078-0414-20, 00078-0414-61, 00078-0415-20, 00078-0415-61, 00078-0417-20, 00078-0417-61, 00078-0422-20, 00078-0422-61, 00078-0566-51, 00078-0566-61, 00078-0567-51, 00078-0567-61, 00078-0594-51, 00078-0594-61, 00078-0620-51, 00078-0620-61, 00078-0626-51, 00078-0626-61, 00078-0627-51, 00078-0627-61, 00078-0628-51, 00078-0628-61, 67877-0721-31, 67877-0719-31, 67877-0720-31, 67877-0718-31, 00054-0470-21, 00054-0471-21, 00054-0472-21, 00054-0480-13, 00054-0480-14, 00054-0481-13, 00054-0481-14, 00054-0497-13, 00054-0497-14, 00054-0604-21, 49884-0160-02, 49884-0283-02

Primary Type:

Oncology

Generic Status:

Multi-Source

Route of Administration:

Oral

About:

AFINITOR is an Oncology drug manufactured by Novartis and administered via the Oral route of administration. The J Code: J7527 is aligned to the drug AFINITOR.